Hanging Context
Tag context panel / topic

Drug Development context for AI agents

Public aggregate context for this entity or topic: appearances, source breadth, streams, related tags, and freshness. This page is built for citation, not retrieval.

Last observed: 2026-08-25 / JSON twin: /data/tags/topic/drug-development.json

Appearances 24h
31
aggregate signals
Appearances 7d
71
aggregate signals
Appearances 30d
599
aggregate signals
Sources
270
distinct source panels
Streams
224
distinct streams
State
Active
quiet / active / surging

Source coverage

earnings-call-transcripts 50
nih-clinical-trials-phase-2-completed-results 29
nih-clinical-trials-phase-3-completed-results 27
nih-clinical-trials-phase-1-completed-results 21
chemrxiv-drug-discovery-medicinal-chemistry 16
earnings-release-globenewswire 11
monopar-therapeutics-ir-news 9
chemrxiv-ai-ml-automation 8
apnimed-news 7
asimov-news-research 7

Streams

U.S. Securities and Exchange Commission 213
U.S. Department of Health and Human Services 80
Earnings Transcripts 50
ChemRxiv 39
Corporate Earnings 12
GSK 8
medRxiv 8
AstraZeneca 7
Lantern Pharma 5
Roche 5

Related topics and entities

Clinical Trial (topic) 400
United States Securities and Exchange Commission (organization) 222
Oncology (topic) 168
U.S. Department of Health and Human Services (organization) 145
Corporate Earnings (topic) 89
FDA Approval (topic) 89
Phase 3 Trial (topic) 81
Food and Drug Administration (organization) 80
Rare Disease (topic) 59
Phase 2 Trial (topic) 57
ChemRxiv (organization) 39
Securities Law (topic) 34

Boundary

Hanging Context publishes aggregate appearances, freshness, and graph relationships. Detailed records, full history, filtering, and delivery belong in Synorb.